metformin and trientine

metformin has been researched along with trientine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bacon, S; Hamilton, DL; Harthill, J; Jiang, H; Logie, L; Macrae, K; McDougall, G; Patel, K; Prescott, AR; Rena, G; Sakamoto, K; Wang, HH; Xue, L	1

Other Studies

2 other study(ies) available for metformin and trientine

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cellular responses to the metal-binding properties of metformin. Diabetes, 2012, Volume: 61, Issue:6 Topics: Adenylate Kinase; Animals; Cell Line; Cells, Cultured; Chelating Agents; Copper; Glucose; Hepatocytes; Hypoglycemic Agents; Metformin; Oxygen Consumption; Phosphorylation; Rats; Ribosomal Protein S6 Kinases; Signal Transduction; Trientine	2012

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Cellular responses to the metal-binding properties of metformin.

Diabetes, 2012, Volume: 61, Issue:6

Topics: Adenylate Kinase; Animals; Cell Line; Cells, Cultured; Chelating Agents; Copper; Glucose; Hepatocytes; Hypoglycemic Agents; Metformin; Oxygen Consumption; Phosphorylation; Rats; Ribosomal Protein S6 Kinases; Signal Transduction; Trientine

2012